CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972-2-532-7151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-02 | LIEBERMAN GERALD M Director | Grant or award · Stock Option (right to buy) | +89,041 | 89,041 | ||
| 2023-01-02 | Mayron Ron Director | Grant or award · Stock Option (right to buy) | +89,041 | 89,041 | ||
| 2023-01-02 | OSTROV GERALD M Director | Grant or award · Stock Option (right to buy) | +89,041 | 89,041 | ||
| 2023-01-02 | Malca Yonatan Director | Grant or award · Stock Option (right to buy) | +89,041 | 89,041 | ||
| 2023-01-02 | Ellis Sean Director | Grant or award · Stock Option (right to buy | +89,041 | 89,041 | ||
| 2022-11-14 | Yaacov-Garbeli Dana Chief Financial Officer | Purchase | +26,580 | $0.54 | $14K | 56,580 |
| 2022-11-14 | LIEBERMAN GERALD M Director | Purchase | +34,000 | $0.57 | $19K | 194,209 |
| 2022-11-14 | LIEBERMAN GERALD M Director | Purchase | +4,000 | $0.56 | $2K | 6,200 |
| 2022-11-14 | LIEBERMAN GERALD M Director | Purchase | +4,000 | $0.56 | $2K | 6,200 |
| 2022-11-14 | LIEBERMAN GERALD M Director | Purchase | +4,000 | $0.56 | $2K | 6,200 |
| 2022-11-14 | LIEBERMAN GERALD M Director | Purchase | +4,000 | $0.59 | $2K | 6,200 |
| 2022-11-11 | Yaacov-Garbeli Dana Chief Financial Officer | Purchase | +30,000 | $0.52 | $16K | 30,000 |
| 2022-11-11 | Ellis Sean Director | Purchase | +30,000 | $0.53 | $16K | 62,100 |
| 2022-11-11 | Toledano Miranda Jayne Chief Executive Officer | Purchase | +50,000 | $0.53 | $27K | 56,800 |
| 2022-09-07 | Santora Arthur C II Chief Medical Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-09-07 | Toledano Miranda Jayne Chief Executive Officer | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2022-09-07 | Toledano Miranda Jayne Chief Executive Officer | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2022-09-07 | Yaacov-Garbeli Dana Chief Financial Officer | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2022-07-21 | Ellis Sean Director | Purchase | +14,900 | $1.64 | $24K | 32,100 |
| 2022-07-21 | LIEBERMAN GERALD M Director | Purchase | +19,491 | $1.68 | $33K | 160,209 |
Page 6 of 8 · 147 trades